SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-08-002570
Filing Date
2008-05-16
Accepted
2008-05-15 19:37:45
Documents
2
Period of Report
2008-05-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_27251.htm 8-K 9734
2 EX-99.1 exhibit1.htm EX-99.1 5597
  Complete submission text file 0001299933-08-002570.txt   16791
Mailing Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Business Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111 (212) 887-6500
Omrix Biopharmaceuticals, Inc. (Filer) CIK: 0001349426 (see all company filings)

IRS No.: 522147005 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51905 | Film No.: 08840061
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1